Overview

Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy

Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether the combination of the the three drugs gabapentin, duloxetine, and donepezil are effective in treating pain in people with diabetic neuropathy or patients with failed low back syndrome (chronic back pain).
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Donepezil
Duloxetine Hydrochloride
Gabapentin
gamma-Aminobutyric Acid